Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/445DDF38.svg?ark=w1%2F20260515%2F445DDF38)](https://nobleid.org/work/w1/20260515/445DDF38)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors